Gossamer Bio, Inc.
GOSS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$56,528 | -$179,817 | -$229,378 | -$234,004 |
| Dep. & Amort. | $4,151 | $4,385 | $4,429 | $5,167 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $20,619 | $28,518 | $42,553 | $32,008 |
| Change in WC | $39,460 | -$14,841 | -$4,459 | $774 |
| Other Non-Cash | -$11,170 | $2,597 | -$177 | $7,165 |
| Operating Cash Flow | -$3,468 | -$159,158 | -$187,032 | -$188,890 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$475 | -$1,546 |
| Net Acquisitions | $0 | $0 | -$65 | $0 |
| Inv. Purchases | -$494,777 | -$441,670 | -$238,060 | -$152,031 |
| Inv. Sales/Matur. | $523,800 | $330,700 | $237,500 | $36,225 |
| Other Inv. Act. | $0 | $0 | $65 | -$75 |
| Investing Cash Flow | $29,023 | -$110,970 | -$1,035 | -$117,427 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$12,581 | -$11,613 | -$5,806 | $0 |
| Stock Issued | $464 | $201,323 | $119,946 | $0 |
| Stock Repurch. | $629 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $888 | $2,950 | $3,329 |
| Financing Cash Flow | -$11,488 | $190,154 | $117,090 | $3,329 |
| Forex Effect | -$102 | $110 | -$517 | -$165 |
| Net Chg. in Cash | $13,965 | -$79,864 | -$71,494 | -$303,153 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $32,109 | $111,973 | $183,467 | $486,620 |
| End Cash | $46,074 | $32,109 | $111,973 | $183,467 |
| Free Cash Flow | -$3,468 | -$159,158 | -$187,507 | -$190,511 |